Skip to content

The study on the recovery quality of remimazolam toluenesulfonate when used as a maintenance anesthetic regimen compared with other anesthetic regimens

Observation of the recovery time after general anesthesia maintenance with remimazolam tosylate: A multicenter, bidirectional cohort, real-world study

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126723
Enrollment
Unknown
Registered
2026-06-15
Start date
2026-06-16
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients requiring general anesthesia for surgery.

Interventions

experimental group (Remimazolam Tosilate):None

Sponsors

Shunde Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for elective surgery; 2. American Society of Anesthesiologists (ASA) physical status classification I to III; 3. Patients undergoing general anesthesia; 4. Prospectively enrolled patients who are informed of the study objectives and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with a known allergy to benzodiazepines or any component of remimazolam besylate; 2. Patients with myasthenia gravis; 3. Patients with schizophrenia or severe depression; 4. Patients with a history of abuse of psychotropic or anesthetic drugs; 5. Patients with a history of epilepsy or in a state of epilepticus at screening; 6. Pregnant or lactating women; 7. Any other condition deemed by the investigator to make the patient unsuitable for participation in this clinical study.

Design outcomes

Primary

MeasureTime frame
Time from immediately after surgery to successful resuscitation (minutes);

Secondary

MeasureTime frame
Time from end of surgery to tracheal extubation (minutes).;The incidence of intraoperative circulatory system events (hypertension, hypotension, tachycardia, bradycardia); the cumulative dosage of intraoperative vasoactive drugs.;The incidence of adverse reactions such as dizziness, nausea, vomiting, and postoperative delirium within 24 hours after surgery.;Injection pain incidence;Quality of Recovery score at 24 hours postoperatively.;

Countries

China

Contacts

Public ContactXianping Wu

Shunde Hospital of Guangzhou University of Traditional Chinese Medicine

sdwxp@163.com+86 757 25382313

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026